CXC-ELR
The antibodies specifically bind seven human ELR+ CXC chemokines are useful for treating various inflammatory/autoimmune diseases, such as inflammatory bowel disease (IBD), plaque psoriasis, and palmoplantar pustulosis; and cancer, such as renal cancer or ovarian cancer.
Species Reactivity: Human
Compare
Species Reactivity: Human
Type: ADCC enhanced antibody
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Species Reactivity: Human
Type: Humanized Fab
Application: Neutralizing Assay, WB
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Species Reactivity: Human
Type: Humanized scFv
Application: Neutralizing Assay, WB
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Type: Humanized antibody
Application: Binding assay
Compare
Species Reactivity: Human
Type: Humanized antibody
Application: Neutralizing Assay, WB
Compare
Species Reactivity: Human
Type: Antibody
Compare
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.